STELLARIS PHARMACEUTICALS ApS Financials, key figures and credit report
Gross profit - 475.3 kDKK FY 2025 -41.3% vs 2024
EBIT -1 014.8 kDKK FY 2025 -15.7% vs 2024
Net debt 4 299.6 kDKK FY 2025 +17.2% vs 2024
Quick ratio 0.2 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 101.61 | - 162.41 | - 255.84 | - 336.36 | - 475.26 |
| Employee benefit expenses | - 588.57 | - 603.13 | - 528.54 | - 521.40 | - 520.56 |
| Total depreciation | -19.00 | -19.00 | -19.00 | -19.00 | |
| EBIT | - 690.17 | - 784.53 | - 803.38 | - 876.76 | -1 014.82 |
| Other financial expenses | -0.75 | -1.46 | -0.05 | -0.80 | |
| Pre-tax profit | - 690.93 | - 785.99 | - 803.43 | - 877.55 | -1 014.82 |
| Income taxes | 152.02 | 390.61 | 419.94 | ||
| Net earnings | - 538.91 | - 785.99 | - 803.43 | - 486.94 | - 594.88 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 360.93 | 341.93 | 322.93 | 303.94 | |
| Tangible assets total | 360.93 | 341.93 | 322.93 | 303.94 | |
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 8.45 | 72.08 | 16.81 | 23.29 | 42.57 |
| Current deferred tax assets | 152.02 | 390.61 | 419.94 | ||
| Short term receivables total | 160.47 | 72.08 | 16.81 | 413.90 | 462.51 |
| Cash and bank deposits | 84.28 | 97.10 | 29.75 | 252.48 | 529.52 |
| Cash and cash equivalents | 84.28 | 97.10 | 29.75 | 252.48 | 529.52 |
| Balance sheet total (assets) | 244.75 | 530.11 | 388.49 | 989.31 | 1 295.96 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Retained earnings | - 435.67 | - 974.57 | -1 760.56 | -2 563.99 | -3 050.93 |
| Profit of the financial year | - 538.91 | - 785.99 | - 803.43 | - 486.94 | - 594.88 |
| Shareholders equity total | - 894.58 | -1 680.56 | -2 483.99 | -2 970.93 | -3 565.82 |
| Non-current liabilities total | |||||
| Current trade creditors | 12.50 | 12.50 | 12.50 | 12.50 | 12.50 |
| Current owed to group member | 1 046.46 | 2 171.74 | 2 820.74 | 3 919.74 | 4 829.13 |
| Other non-interest bearing current liabilities | 80.36 | 26.43 | 39.24 | 28.00 | 20.14 |
| Current liabilities total | 1 139.33 | 2 210.68 | 2 872.48 | 3 960.25 | 4 861.78 |
| Balance sheet total (liabilities) | 244.75 | 530.11 | 388.49 | 989.31 | 1 295.96 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated